SCHEMBL30921473

SCHEMBL30921473

CN(C(=O)CN1CCC1)c1ccc(N)cc1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
DRD4 P21917 1/20 0.49
HRH3 Q9Y5N1 1/20 0.47
LMNA P02545 1/20 0.44
RAD52 P43351 2/20 0.42
OPRK1 P41145 1/20 0.41
PPIB P23284 2/20 0.40
GFER P55789 2/20 0.39
SIGMAR1 Q99720 1/20 0.39
ALDH1A1 P00352 3/20 0.39
POLQ O75417 2/20 0.39
AURKA O14965 1/20 0.38
SLC6A3 Q01959 1/20 0.38
CASP6 P55212 1/20 0.37
TP53 P04637 1/20 0.37
CYP3A4 P08684 1/20 0.37
ALOX15 P16050 1/20 0.37
MAPK1 P28482 1/20 0.37
TDP1 Q9NUW8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3158672 0.97 DRD4 (0.49) DRD4HRH3LMNARAD52OPRK1
SCHEMBL3148838 0.95 DRD4 (0.48) DRD4HRH3LMNARAD52OPRK1
SCHEMBL4490990 0.92 DRD4 (0.46) DRD4HRH3LMNASIGMAR1MAPK1
SCHEMBL4487965 0.88 DRD4 (0.50) DRD4HRH3LMNARAD52PPIB
SCHEMBL436539 0.88 DRD4 (0.50) DRD4HRH3LMNAGFERALDH1A1
SCHEMBL24538671 0.87 DRD4 (0.49) DRD4HRH3LMNAOPRK1PPIB
SCHEMBL18851564 0.87 DRD4 (0.46) DRD4HRH3LMNAPPIBSIGMAR1
SCHEMBL3144650 0.87 HRH3 (0.58) DRD4HRH3LMNAALDH1A1TP53
SCHEMBL17976084 0.85 DRD4 (0.48) DRD4HRH3LMNAPPIBALDH1A1
SCHEMBL8354585 0.83 LMNA (0.61) DRD4HRH3LMNASIGMAR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612149-A1 PYRIDO[2,3-D]PYRIMIDIN-2-AMINE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER Cancer Research Technology Limited (GB) 2025-09-10 EP disclosed